Feed Insights Top Reports Pricing

⌘K

00:15:28·40d

SECFilingvia Quantisnow

SEC Form EFFECT filed by Upexi Inc.

ByQuantisnow·Wall Street's wire, on your screen.

UPXI· Upexi Inc.

Health Care

#watchlistBeagle is online

BeagleApp12:15 AM

Heads up - $UPXI just posted a new SEC filing. Here is the headline that moved it:

SEC Form EFFECT filed by Upexi Inc.

Sourced from the filing - want the 30-second brief? Never financial advice.

Hire Beagle to watch $UPXI

👀7🚀4🐶3

Plus alert sent

Quantisnow Plus members were alerted at 00:15:28 ET - 0.6s after publication.

Sign up for Plus

beagle.

by Alamere Labs

Now hiring

Your first full-time market-watch teammate

Market research that briefs you, before the bell.

Beagle watches $UPXI across price, news, SEC filings and the macro calendar, drafts the morning brief, and pings you the moment a name moves - sourced every time, and never financial advice.

Price levelsSEC filingsBreaking newsMacro calendar

Hire Beagle See an alertLives in Slack & Teams

Free Quantisnow account

Get notified the moment UPXI files

Real-time alerts on SEC filings, FDA approvals, analyst ratings, insider trades, and press releases. Follow any ticker. No credit card.

Sign up free Log in

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track UPXI (Upexi Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Upexi Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
Director Salkind Gene was granted 100,000 shares, increasing direct ownership by 46% to 318,750 units (SEC Form 4)
Director Dugan Lawrence was granted 100,000 shares, increasing direct ownership by 86% to 216,389 units (SEC Form 4)
Chief Strategy Officer Rudick Brian Benjamin was granted 400,000 shares, increasing direct ownership by 48% to 1,238,597 units (SEC Form 4)
Chief Executive Officer Marshall Allan was granted 2,000,000 shares, increasing direct ownership by 49% to 6,046,261 units (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022